Global Oncolytic Virus Immunotherapy Market Research Report 2023

Report ID: 1917427 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Engineering Oncolytic Viruses
        1.2.3 Wild-Type Oncolytic Viruses
    1.3 Market by Application
        1.3.1 Global Oncolytic Virus Immunotherapy Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Ambulatory Surgical Centers
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Oncolytic Virus Immunotherapy Market Perspective (2017-2028)
    2.2 Oncolytic Virus Immunotherapy Growth Trends by Region
        2.2.1 Oncolytic Virus Immunotherapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Oncolytic Virus Immunotherapy Historic Market Size by Region (2017-2022)
        2.2.3 Oncolytic Virus Immunotherapy Forecasted Market Size by Region (2023-2028)
    2.3 Oncolytic Virus Immunotherapy Market Dynamics
        2.3.1 Oncolytic Virus Immunotherapy Industry Trends
        2.3.2 Oncolytic Virus Immunotherapy Market Drivers
        2.3.3 Oncolytic Virus Immunotherapy Market Challenges
        2.3.4 Oncolytic Virus Immunotherapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Oncolytic Virus Immunotherapy Players by Revenue
        3.1.1 Global Top Oncolytic Virus Immunotherapy Players by Revenue (2017-2022)
        3.1.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Players (2017-2022)
    3.2 Global Oncolytic Virus Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Oncolytic Virus Immunotherapy Revenue
    3.4 Global Oncolytic Virus Immunotherapy Market Concentration Ratio
        3.4.1 Global Oncolytic Virus Immunotherapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Immunotherapy Revenue in 2021
    3.5 Oncolytic Virus Immunotherapy Key Players Head office and Area Served
    3.6 Key Players Oncolytic Virus Immunotherapy Product Solution and Service
    3.7 Date of Enter into Oncolytic Virus Immunotherapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Immunotherapy Breakdown Data by Type
    4.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Type (2017-2022)
    4.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2023-2028)
5 Oncolytic Virus Immunotherapy Breakdown Data by Application
    5.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Application (2017-2022)
    5.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Oncolytic Virus Immunotherapy Market Size (2017-2028)
    6.2 North America Oncolytic Virus Immunotherapy Market Size by Country (2017-2022)
    6.3 North America Oncolytic Virus Immunotherapy Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Oncolytic Virus Immunotherapy Market Size (2017-2028)
    7.2 Europe Oncolytic Virus Immunotherapy Market Size by Country (2017-2022)
    7.3 Europe Oncolytic Virus Immunotherapy Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Oncolytic Virus Immunotherapy Market Size (2017-2028)
    8.2 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Country (2017-2022)
    8.3 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Oncolytic Virus Immunotherapy Market Size (2017-2028)
    9.2 Latin America Oncolytic Virus Immunotherapy Market Size by Country (2017-2022)
    9.3 Latin America Oncolytic Virus Immunotherapy Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Oncolytic Virus Immunotherapy Market Size (2017-2028)
    10.2 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2017-2022)
    10.3 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Oncolytic Virus Immunotherapy Introduction
        11.1.4 Merck Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
        11.1.5 Merck Recent Development
    11.2 Amgen
        11.2.1 Amgen Company Detail
        11.2.2 Amgen Business Overview
        11.2.3 Amgen Oncolytic Virus Immunotherapy Introduction
        11.2.4 Amgen Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
        11.2.5 Amgen Recent Development
    11.3 TILT Biotherapeutics
        11.3.1 TILT Biotherapeutics Company Detail
        11.3.2 TILT Biotherapeutics Business Overview
        11.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Introduction
        11.3.4 TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
        11.3.5 TILT Biotherapeutics Recent Development
    11.4 Oncorus
        11.4.1 Oncorus Company Detail
        11.4.2 Oncorus Business Overview
        11.4.3 Oncorus Oncolytic Virus Immunotherapy Introduction
        11.4.4 Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
        11.4.5 Oncorus Recent Development
    11.5 Sorrento Therapeutics
        11.5.1 Sorrento Therapeutics Company Detail
        11.5.2 Sorrento Therapeutics Business Overview
        11.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Introduction
        11.5.4 Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
        11.5.5 Sorrento Therapeutics Recent Development
    11.6 Shanghai Sunway Biotech
        11.6.1 Shanghai Sunway Biotech Company Detail
        11.6.2 Shanghai Sunway Biotech Business Overview
        11.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Introduction
        11.6.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2017-2022)
        11.6.5 Shanghai Sunway Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Engineering Oncolytic Viruses
    Table 3. Key Players of Wild-Type Oncolytic Viruses
    Table 4. Global Oncolytic Virus Immunotherapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Oncolytic Virus Immunotherapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Oncolytic Virus Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Oncolytic Virus Immunotherapy Market Share by Region (2017-2022)
    Table 8. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Oncolytic Virus Immunotherapy Market Share by Region (2023-2028)
    Table 10. Oncolytic Virus Immunotherapy Market Trends
    Table 11. Oncolytic Virus Immunotherapy Market Drivers
    Table 12. Oncolytic Virus Immunotherapy Market Challenges
    Table 13. Oncolytic Virus Immunotherapy Market Restraints
    Table 14. Global Oncolytic Virus Immunotherapy Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Oncolytic Virus Immunotherapy Market Share by Players (2017-2022)
    Table 16. Global Top Oncolytic Virus Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Immunotherapy as of 2021)
    Table 17. Ranking of Global Top Oncolytic Virus Immunotherapy Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Oncolytic Virus Immunotherapy Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Oncolytic Virus Immunotherapy Product Solution and Service
    Table 21. Date of Enter into Oncolytic Virus Immunotherapy Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Oncolytic Virus Immunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2017-2022)
    Table 25. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2023-2028)
    Table 27. Global Oncolytic Virus Immunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2017-2022)
    Table 29. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2023-2028)
    Table 31. North America Oncolytic Virus Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Oncolytic Virus Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Oncolytic Virus Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Oncolytic Virus Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Oncolytic Virus Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Oncolytic Virus Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Merck Company Detail
    Table 42. Merck Business Overview
    Table 43. Merck Oncolytic Virus Immunotherapy Product
    Table 44. Merck Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million)
    Table 45. Merck Recent Development
    Table 46. Amgen Company Detail
    Table 47. Amgen Business Overview
    Table 48. Amgen Oncolytic Virus Immunotherapy Product
    Table 49. Amgen Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million)
    Table 50. Amgen Recent Development
    Table 51. TILT Biotherapeutics Company Detail
    Table 52. TILT Biotherapeutics Business Overview
    Table 53. TILT Biotherapeutics Oncolytic Virus Immunotherapy Product
    Table 54. TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million)
    Table 55. TILT Biotherapeutics Recent Development
    Table 56. Oncorus Company Detail
    Table 57. Oncorus Business Overview
    Table 58. Oncorus Oncolytic Virus Immunotherapy Product
    Table 59. Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million)
    Table 60. Oncorus Recent Development
    Table 61. Sorrento Therapeutics Company Detail
    Table 62. Sorrento Therapeutics Business Overview
    Table 63. Sorrento Therapeutics Oncolytic Virus Immunotherapy Product
    Table 64. Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million)
    Table 65. Sorrento Therapeutics Recent Development
    Table 66. Shanghai Sunway Biotech Company Detail
    Table 67. Shanghai Sunway Biotech Business Overview
    Table 68. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product
    Table 69. Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2017-2022) & (US$ Million)
    Table 70. Shanghai Sunway Biotech Recent Development
    Table 71. Research Programs/Design for This Report
    Table 72. Key Data Information from Secondary Sources
    Table 73. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncolytic Virus Immunotherapy Market Share by Type: 2021 VS 2028
    Figure 2. Engineering Oncolytic Viruses Features
    Figure 3. Wild-Type Oncolytic Viruses Features
    Figure 4. Global Oncolytic Virus Immunotherapy Market Share by Application in 2021 & 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Ambulatory Surgical Centers Case Studies
    Figure 8. Oncolytic Virus Immunotherapy Report Years Considered
    Figure 9. Global Oncolytic Virus Immunotherapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Oncolytic Virus Immunotherapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Oncolytic Virus Immunotherapy Market Share by Region: 2021 VS 2028
    Figure 12. Global Oncolytic Virus Immunotherapy Market Share by Players in 2021
    Figure 13. Global Top Oncolytic Virus Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Immunotherapy as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Oncolytic Virus Immunotherapy Revenue in 2021
    Figure 15. North America Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Oncolytic Virus Immunotherapy Market Share by Country (2017-2028)
    Figure 17. United States Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Oncolytic Virus Immunotherapy Market Share by Country (2017-2028)
    Figure 21. Germany Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Oncolytic Virus Immunotherapy Market Share by Region (2017-2028)
    Figure 29. China Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Oncolytic Virus Immunotherapy Market Share by Country (2017-2028)
    Figure 37. Mexico Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Oncolytic Virus Immunotherapy Market Share by Country (2017-2028)
    Figure 41. Turkey Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Oncolytic Virus Immunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Merck Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2022)
    Figure 44. Amgen Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2022)
    Figure 45. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2022)
    Figure 46. Oncorus Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2022)
    Figure 47. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2022)
    Figure 48. Shanghai Sunway Biotech Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2017-2022)
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Amgen
TILT Biotherapeutics
Oncorus
Sorrento Therapeutics
Shanghai Sunway Biotech
Frequently Asked Questions
Oncolytic Virus Immunotherapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncolytic Virus Immunotherapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncolytic Virus Immunotherapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Online Apparel

Market Analysis and Insights: Global Online Apparel Market
It has been noticed that ... Read More

Nursing Clogs

Clogs are a popular piece of footwear in the nursing community. Clogs provide nurses with better  ... Read More